Silo Brook Capital (“SBC”) is a Boston based private equity firm specialized in acquiring and scaling small-cap nutraceutical direct-to-consumer (“DTC”) brands distributing on the Amazon.com platform. Additionally, SBC is active in US real estate with a generalist approaching acquiring real estate as a sole GP or Co-GP. Our value as a Co-GP is fostered around the ability to provide balance sheet support and fill the capital stack through long standing LP relationships enabling experienced owner/operators to scale up. SBC’s investment philosophy for its nutraceutical buyouts platform fosters around three key principles: (1) Identifying & investing in brands with proven economic moats on the Amazon platform; (2) targeting category leaders within niche markets with double digit market growth attractive for future acquisitions; and (3) exclusively acquiring brands that have the potential to distribute within big-box retail stores such as GNC, Vitamin Shoppe, Walgreens & CVS.